Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Wouter Jukema

Showing results (681-690 of 928) with videos related to

Pageof 93
Sort By:
Plos One|September 26, 2013
BMP7 activates brown adipose tissue and reduces diet-induced obesity only at subthermoneutralityMariëtte R Boon, Sjoerd A A van den Berg, Yanan Wang, et al.
Journal of the American College of Cardiology|March 23, 2019
Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome: ODYSSEY OUTCOMES TrialJ Wouter Jukema, Michael Szarek, Laurien E Zijlstra, et al.
International Journal of Epidemiology|January 16, 2014
Leukocyte telomere length associates with prospective mortality independent of immune-related parameters and known genetic markersJoris Deelen, Marian Beekman, Veryan Codd, et al.
Journal of the American College of Cardiology|September 4, 2024
Triglyceride Levels, Alirocumab Treatment, and Cardiovascular Outcomes After an Acute Coronary SyndromeDoron Zahger, Gregory G Schwartz, Weiming Du, et al.
Frontiers in Endocrinology|June 7, 2021
Levothyroxine Treatment and Cardiovascular Outcomes in Older People With Subclinical Hypothyroidism: Pooled Individual Results of Two Randomised Controlled TrialsLaurien E Zijlstra, J Wouter Jukema, Rudi G J Westendorp, et al.
The Pharmacogenomics Journal|December 6, 2019
Statin-induced LDL cholesterol response and type 2 diabetes: a bidirectional two-sample Mendelian randomization studyRoelof A J Smit, Stella Trompet, Aaron Leong, et al.
Plos One|August 15, 2014
Increased platelet reactivity is associated with circulating platelet-monocyte complexes and macrophages in human atherosclerotic plaquesBert Rutten, Claudia Tersteeg, Joyce E P Vrijenhoek, et al.
Circulation. Cardiovascular Genetics|March 1, 2012
Literature-based genetic risk scores for coronary heart disease: the Cardiovascular Registry Maastricht (CAREMA) prospective cohort studyAnika A M Vaarhorst, Yingchang Lu, Bastiaan T Heijmans, et al.
American Heart Journal|September 5, 2024
Low-dose colchicine for the prevention of cardiovascular events after percutaneous coronary intervention: Rationale and design of the COL BE PCI trialEmmanuel De Cock, Shakeel Kautbally, Frank Timmermans, et al.
The New England Journal of Medicine|June 4, 2015
Ezetimibe Added to Statin Therapy after Acute Coronary SyndromesChristopher P Cannon, Michael A Blazing, Robert P Giugliano, et al.
Pageof 93

Showing results (681-690 of 928) with videos related to

Sort By:
Pageof 93
Plos One|September 26, 2013
BMP7 activates brown adipose tissue and reduces diet-induced obesity only at subthermoneutralityMariëtte R Boon, Sjoerd A A van den Berg, Yanan Wang, et al.
Journal of the American College of Cardiology|March 23, 2019
Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome: ODYSSEY OUTCOMES TrialJ Wouter Jukema, Michael Szarek, Laurien E Zijlstra, et al.
International Journal of Epidemiology|January 16, 2014
Leukocyte telomere length associates with prospective mortality independent of immune-related parameters and known genetic markersJoris Deelen, Marian Beekman, Veryan Codd, et al.
Journal of the American College of Cardiology|September 4, 2024
Triglyceride Levels, Alirocumab Treatment, and Cardiovascular Outcomes After an Acute Coronary SyndromeDoron Zahger, Gregory G Schwartz, Weiming Du, et al.
Frontiers in Endocrinology|June 7, 2021
Levothyroxine Treatment and Cardiovascular Outcomes in Older People With Subclinical Hypothyroidism: Pooled Individual Results of Two Randomised Controlled TrialsLaurien E Zijlstra, J Wouter Jukema, Rudi G J Westendorp, et al.
The Pharmacogenomics Journal|December 6, 2019
Statin-induced LDL cholesterol response and type 2 diabetes: a bidirectional two-sample Mendelian randomization studyRoelof A J Smit, Stella Trompet, Aaron Leong, et al.
Plos One|August 15, 2014
Increased platelet reactivity is associated with circulating platelet-monocyte complexes and macrophages in human atherosclerotic plaquesBert Rutten, Claudia Tersteeg, Joyce E P Vrijenhoek, et al.
Circulation. Cardiovascular Genetics|March 1, 2012
Literature-based genetic risk scores for coronary heart disease: the Cardiovascular Registry Maastricht (CAREMA) prospective cohort studyAnika A M Vaarhorst, Yingchang Lu, Bastiaan T Heijmans, et al.
American Heart Journal|September 5, 2024
Low-dose colchicine for the prevention of cardiovascular events after percutaneous coronary intervention: Rationale and design of the COL BE PCI trialEmmanuel De Cock, Shakeel Kautbally, Frank Timmermans, et al.
The New England Journal of Medicine|June 4, 2015
Ezetimibe Added to Statin Therapy after Acute Coronary SyndromesChristopher P Cannon, Michael A Blazing, Robert P Giugliano, et al.
Pageof 93